The aminopeptidase inhibitor——bestatin induces apoptosis in human leukemic cells

林茂芳,何静松,钱文斌,麦文渊

DOI: https://doi.org/10.3969/j.issn.1001-8689.2001.03.015

2001-01-01

Abstract:Objective: To study the mechanism of actions of bestatin inhibiting human leukemic cells. Methods: K562 and HL60 cells were treated with bestatin at different concentrations and growth inhibition phases and were analysed by MTT assay. Cell apoptosis was evaluated by light microscopy, agarose gel electrophoresis, TUNEL labeling method and flow cytometry (FCM) assay. The mitochondrial transmembrane potentials (ΔΨm) were detected through staining of Rhodamine 123, of which fluorescent intensities were measured on FCM. Results: 1. Treatment with bestatin remarkably inhibited the growth of HL60 cells, the IC50 value of bestatin for HL60 cells was found to be 13.03μg/ml. But K562 cells were less sensitive than HL60, the IC50 value for K562 cells was more than 400μg/ml. Bestatin inhibited the growth of HL60 and K562 cells in a dose- time dependent manner; 2. Apoptosis of leukemic cells could be induced by bestatin, showing the apoptotic changes in morphology, DNA ladder on agarose gel, labeled by TUNEL method, apoptotic peak before G1 phase of cell cycle; 3. Bestatin induced apoptosis in K562 and HL60 cells in a dose-time dependent manner; 4. The cell cycle analysis measured by FCM showed that the cells were in G1 blocking after treated with bestatin; 5. The ΔΨm of cells collapse was induced by bestatin. Conclusion: Bestatin could efficiently induce apoptosis in HL60 and K562 cells, and this is one of the mechanisms for inhibiting leukemia of bestatin, which could be associated closely with the ΔΨm collapse induced by bestatin.